Covid-19: Pune-based drug firm to export favipiravir to 18 countries

Pune-based pharmaceutical marketing company Brinton Pharmaceuticals is gearing up to export anti-viral drug favipiravir to 18 countries and awaiting approval from the Indian drug controller to launch the drug in India. Favipiravir is under trial in many countries as a potential treatment for Covid-19, and in India, Glenmark Pharmaceuticals is conducting the trials that have entered phase 3.

After the trials are over in India, the Drug Controller General of India (DCGI) is likely to give the nod to market the drug here which was originally developed by Japan's Fujifilm Toyama Chemical Co Ltd, a subsidiary of Fujifilm Corporation. The